Replenish Health Spa
- IV Therapy
- Laser Therapy (LLLT)
- Arthritis Treatment
- Peptide Therapy
- Red Light Therapy
Raleigh, NC
Raleigh stem-cell marketing clusters where cash-pay orthopedics, interventional pain menus, and regenerative injection suites meet Research Triangle daytime traffic and mild-winter weekend recovery. You will see same-day bone marrow or adipose products, cord-blood marketing, and "regenerative" menus across North Hills and Midtown offices, Downtown Raleigh and Glenwood South corridors, Brier Creek suites, and Cary–Durham–Chapel Hill spillover that still filters under the Raleigh Directory. An RTP commute or a Fayetteville Street walk does not change product quality. The same "stem cell" label can mean very different cell sources, processing steps, and evidence grades.
This hub lists clinics that appear in our Directory for Raleigh and stem-cell therapy. Inclusion is not an endorsement, and listing order is not a paid ranking. Regenerated.com is free for patients. Organic relevance and published evidence signals are separate from any labeled Featured or Sponsored placement. Verified badges, when present, reflect credential checks (not spend).
When you compare options here, ask what product is actually injected, whether it is same-day autologous or banked allogeneic material, who performs the procedure, what imaging guides it, and which outcomes they track. University and research-hospital adjacent branding in the Triangle is marketing gravity, not a protocol. Duke and UNC are nearby institutional brands; do not treat their names as a substitute for private Raleigh clinic product diligence. Regenerated does not invent Raleigh average prices; clinic quotes vary too widely by product and body site for a single range to be honest.
Prefer clinicians who can explain FDA IND/BLA boundaries and federal 21 CFR 1271 HCT/P rules in plain language, document informed consent under North Carolina Medical Board expectations, and separate marketing claims from published evidence. Use national stem-cell Guides for mechanism literacy, then return here for Raleigh listings.
Regulatory context
North Carolina cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in North Carolina for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. The Research Triangle hosts substantial academic IND-based regenerative medicine research.
The FDA has issued warning letters to North Carolina clinics offering stem cell and exosome therapies. The North Carolina Medical Board has disciplined physicians for unprofessional conduct including misleading regenerative medicine advertising. The North Carolina Attorney General has used the Unfair and Deceptive Trade Practices Act to pursue providers making unsupported clinical claims, and Chapter 75 enables private class actions with treble damages, which raises the financial risk for noncompliant providers. Federal warning letters apply nationally.
Available here
Nationwide
Stem Cell Therapy clinics across the US